Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ezio Fornasiere

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Journal of Clinical Medicine|September 10, 2021
Liver Transplantation in Patients with Hepatocellular Carcinoma beyond the Milan Criteria: A Comprehensive ReviewPierluigi Toniutto, Elisa Fumolo, Ezio Fornasiere, et al.
Minerva Gastroenterologica E Dietologica|October 11, 2018
Challenges and future developments in liver transplantationPierluigi Toniutto, Davide Bitetto, Ezio Fornasiere, et al.
Recenti Progressi in Medicina|January 23, 2019
[New organ allocation criteria in liver transplantation.]Pierluigi Toniutto, Ezio Fornasiere, Elisa Fumolo, et al.
Discovery Medicine|March 9, 2007
Updates on antiviral therapy for chronic hepatitis CPierluigi Toniutto, Carlo Fabris, Davide Bitetto, et al.
Idrugs : the Investigational Drugs Journal|October 2, 2008
R-1626, a specific oral NS5B polymerase inhibitor of hepatitis C virusPierluigi Toniutto, Carlo Fabris, Davide Bitetto, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|March 3, 2007
Valopicitabine dihydrochloride:a specific polymerase inhibitor of hepatitis C virusPierluigi Toniutto, Carlo Fabris, Davide Bitetto, et al.
Transplantation|January 25, 2023
Complete Endovascular Stenting of the Inferior Vena Cava Following Its Twisting After Liver TransplantationPierluigi Toniutto, Alessandro Vit, Davide Bitetto, et al.
Journal of Clinical Medicine|July 12, 2025
Efficacy and Safety of GLP-1 Receptor Agonists and SGLT-2 Inhibitors in the Treatment of Diabetes Mellitus and Obesity in Liver Transplant Recipients: A Systematic ReviewElena Garlatti Costa, Davide Bitetto, Ezio Fornasiere, et al.
Therapeutics and Clinical Risk Management|October 2, 2008
Antiviral treatment in patients with hepatitis C virus-related cirrhosis awaiting liver transplantationPierluigi Toniutto, Carlo Fabris, Davide Bitetto, et al.
Journal of Gastroenterology|July 27, 2007
Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantationCarlo Fabris, Pierluigi Toniutto, Davide Bitetto, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal of Clinical Medicine|September 10, 2021
Liver Transplantation in Patients with Hepatocellular Carcinoma beyond the Milan Criteria: A Comprehensive ReviewPierluigi Toniutto, Elisa Fumolo, Ezio Fornasiere, et al.
Minerva Gastroenterologica E Dietologica|October 11, 2018
Challenges and future developments in liver transplantationPierluigi Toniutto, Davide Bitetto, Ezio Fornasiere, et al.
Recenti Progressi in Medicina|January 23, 2019
[New organ allocation criteria in liver transplantation.]Pierluigi Toniutto, Ezio Fornasiere, Elisa Fumolo, et al.
Discovery Medicine|March 9, 2007
Updates on antiviral therapy for chronic hepatitis CPierluigi Toniutto, Carlo Fabris, Davide Bitetto, et al.
Idrugs : the Investigational Drugs Journal|October 2, 2008
R-1626, a specific oral NS5B polymerase inhibitor of hepatitis C virusPierluigi Toniutto, Carlo Fabris, Davide Bitetto, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|March 3, 2007
Valopicitabine dihydrochloride:a specific polymerase inhibitor of hepatitis C virusPierluigi Toniutto, Carlo Fabris, Davide Bitetto, et al.
Transplantation|January 25, 2023
Complete Endovascular Stenting of the Inferior Vena Cava Following Its Twisting After Liver TransplantationPierluigi Toniutto, Alessandro Vit, Davide Bitetto, et al.
Journal of Clinical Medicine|July 12, 2025
Efficacy and Safety of GLP-1 Receptor Agonists and SGLT-2 Inhibitors in the Treatment of Diabetes Mellitus and Obesity in Liver Transplant Recipients: A Systematic ReviewElena Garlatti Costa, Davide Bitetto, Ezio Fornasiere, et al.
Therapeutics and Clinical Risk Management|October 2, 2008
Antiviral treatment in patients with hepatitis C virus-related cirrhosis awaiting liver transplantationPierluigi Toniutto, Carlo Fabris, Davide Bitetto, et al.
Journal of Gastroenterology|July 27, 2007
Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantationCarlo Fabris, Pierluigi Toniutto, Davide Bitetto, et al.
Pageof 4